Among these, TP73, XYLB, ALDH4A1, PTPRB, and HLA-DRB5 exhibited high-impact mutations in African American prostate cancer samples, compared to Caucasian white samples Table 2. This evidence concerns the gene HLA-DRB5 and prostate cancer.